Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Anne-Sofie Schrohl"'
Autor:
Vibeke Jensen, Anne-Sofie Schrohl, Nils Brünner, Xiaohong Deng, Jan Stenvang, Louise Fogh, Ulrik Lademann, Huanming Yang
Publikováno v:
Tumor Biology. 34:1161-1170
Tissue inhibitor of metalloproteinases-1 (TIMP-1) has been suggested as a marker of prognosis and response to treatment in breast cancer. In vitro, TIMP-1 can regulate shedding of the extracellular domain of HER2 and signalling via the Akt pathway, a
Autor:
Nils Brünner, Anne-Sofie Schrohl, Yves Pommier, Petra Hamerlik, Magnus Stougaard, John A. Foekens, Birgitta R. Knudsen, Signe Lykke Nielsen, José M.A. Moreira, Marcel Smid, Kristina Aluzaite, Stine Ninel Hansen, John W.M. Martens, Madhavsai K. Gajjar, Julie B. Noer, Britt Damsgaard, Haatisha Jandu, Louise Fogh, Khoa Nguyen Do, Jan Stenvang, Joanna Proszek, Sebastian Wingaard Thrane
Publikováno v:
Jandu, H, Aluzaite, K, Fogh, L, Thrane, S W, Noer, J B, Proszek, J, Do, K N, Hansen, S N, Damsgaard, B, Nielsen, S L, Stougaard, M, Knudsen, B R, Moreira, J, Hamerlik, P, Gajjar, M, Smid, M, Martens, J, Foekens, J, Pommier, Y, Brünner, N, Schrohl, A-S & Stenvang, J 2016, ' Molecular characterization of irinotecan (SN-38) resistant human breast cancer cell lines ', BMC Cancer, vol. 16, no. 1, 34 . https://doi.org/10.1186/s12885-016-2071-1
BMC Cancer
Jandu, H, Aluzaite, K, Fogh, L, Thrane, S W, Noer, J B, Proszek, J, Nguyen Do, K, Hansen, S N, Damsgaard, B, Nielsen, S L, Stougaard, M, Knudsen, B R, Moreira, J, Hamerlik, P, Gajjar, M, Smid, M, Martens, J, Foekens, J, Pommier, Y, Brunner, N, Schrohl, A-S & Stenvang, J 2016, ' Molecular characterization of irinotecan (SN-38) resistant human breast cancer cell lines ', B M C Cancer, vol. 16, no. 1, 34 . https://doi.org/10.1186/s12885-016-2071-1
BMC Cancer, 16:34. BioMed Central Ltd.
BMC Cancer
Jandu, H, Aluzaite, K, Fogh, L, Thrane, S W, Noer, J B, Proszek, J, Nguyen Do, K, Hansen, S N, Damsgaard, B, Nielsen, S L, Stougaard, M, Knudsen, B R, Moreira, J, Hamerlik, P, Gajjar, M, Smid, M, Martens, J, Foekens, J, Pommier, Y, Brunner, N, Schrohl, A-S & Stenvang, J 2016, ' Molecular characterization of irinotecan (SN-38) resistant human breast cancer cell lines ', B M C Cancer, vol. 16, no. 1, 34 . https://doi.org/10.1186/s12885-016-2071-1
BMC Cancer, 16:34. BioMed Central Ltd.
Background Studies in taxane and/or anthracycline refractory metastatic breast cancer (mBC) patients have shown approximately 30 % response rates to irinotecan. Hence, a significant number of patients will experience irinotecan-induced side effects w
Autor:
Haatisha Jandu, Aluzaite, Kristina, Fogh, Louise, Thrane, Sebastian, Noer, Julie, Proszek, Joanna, Do, Khoa, Hansen, Stine, Damsgaard, Britt, Nielsen, Signe, Stougaard, Magnus, Knudsen, Birgitta, Moreira, José, Hamerlik, Petra, Madhavsai Gajjar, Smid, Marcel, Martens, John, Foekens, John, Pommier, Yves, Brünner, Nils, Anne-Sofie Schrohl, Stenvang, Jan
This file contains the following: Table S1: a table with FISH data of TOP1/CEN-20 and TOP2A/CEN-17, TOP1/CEN-20 analyses of 52 human breast cancer cell lines. Figure S1: correlations between TOP1 copynumbers from FISH and SNP analyses, and correlatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e392f9d3c9b2c61d1da24f6b1c08d89
Autor:
Signe Lykke Nielsen, Hans Christian Pedersen, Sussie Steen Jensen, Nils Brünner, Anne-Sofie Schrohl
Publikováno v:
Histopathology
Schrohl A-S, Pedersen H C, Jensen S S, Nielsen S L & Brunner N (2011) Histopathology59, 975–983 Human epidermal growth factor receptor 2 (HER2) immunoreactivity: specificity of three pharmacodiagnostic antibodies Aims: The availability of specific
Autor:
Christoph Thomssen, Klaus Pantel, Anne-Sofie Schrohl, Volkmar Mueller, Nils Bruenner, Ib Jarle Christensen
Publikováno v:
Tumor Biology. 29:181-187
Objective: Tissue inhibitor of metalloproteinases-1 (TIMP-1) has been investigated as a potential tumour marker in breast cancer. Here we investigated the correlation between TIMP-1 in tumour tissue and plasma to evaluate whether TIMP-1 in plasma is
Autor:
Hans Jørgen Nielsen, Anne Sofie Schrohl, Ib Jarle Christensen, Nanna Møller Sørensen, Vibeke Jensen, Nils Brünner
Publikováno v:
Scandinavian Journal of Gastroenterology. 43:186-191
We have recently shown that preoperative plasma tissue inhibitor of metalloproteinases-1 (TIMP-1) levels are significantly associated with prognosis of colorectal cancer patients. In addition, we have shown that measurement of plasma TIMP-1 yields in
Autor:
Marion E. Meijer-van Gelder, Nils Brünner, Henning T. Mouridsen, Ib Jarle Christensen, Anne-Sofie Schrohl, Mads Nikolaj Holten-Andersen, Maxime P. Look, John A. Foekens
Publikováno v:
Clinical Cancer Research. 12:7054-7058
Purpose: Only about 50% of metastatic breast cancer patients benefit from cytotoxic chemotherapy. Today, no validated markers exist for prediction of chemotherapy sensitivity/resistance in this patient group. Tissue inhibitor of metalloproteinases-1
Autor:
Vibeke Jensen, Anne Sofie Schrohl, Ib Jarle Christensen, Ulrik Lademann, Sidse Ørnbjerg Würtz, Nils Brünner, Henning T. Mouridsen
Publikováno v:
Molecular & Cellular Proteomics. 4:483-491
Several studies have demonstrated an association between high tumor tissue levels of total tissue inhibitor of metalloproteinases-1 (TIMP-1) and a poor prognosis of primary breast cancer patients. In the present study we investigated whether measurem
Autor:
Ib Jarle Christensen, Nils Brünner, Ole Kronborg, Anne-Sofie Schrohl Rasmussen, Hans Jørgen Nielsen, Mads Nikolaj Holten-Andersen, Claus Fenger
Publikováno v:
European Journal of Cancer. 40:2159-2164
Colorectal cancer patients have increased plasma levels of tissue inhibitor of metalloproteinases-1 (TIMP-1). However, it remains unresolved whether colorectal adenomas are associated with increased plasma TIMP-1. Plasma TIMP-1 levels were determined
Autor:
Jan G. M. Klijn, Marion E. Meijer-van Gelder, Nils Brünner, Maxine P. Look, Anne-Sofie Schrohl, Mads Nikolaj Holten-Andersen, John A. Foekens, H. A. Peters
Publikováno v:
Clinical Cancer Research. 10:2289-2298
Purpose: In the present study, we investigated the association between tumor tissue levels of tissue inhibitor of metalloproteinase-1 (TIMP-1) and prognosis in patients with primary breast cancer and analyzed whether TIMP-1 may be useful as a prognos